Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Elson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biology|April 28, 2023
Tumor-Suppressive Functions of the Aryl Hydrocarbon Receptor (AhR) and AhR as a Therapeutic Target in CancerDaniel J Elson, Siva K Kolluri
Optics Letters|December 24, 2015
High spectral density transmission emulation using amplified spontaneous emission noiseDaniel J Elson, Lidia Galdino, Robert Maher, et al.
Biology|April 3, 2021
The Zebrafish Xenograft Models for Investigating Cancer and Cancer TherapeuticsJohn T Gamble, Daniel J Elson, Juliet A Greenwood, et al.
FEBS Letters|June 23, 2022
The cyclin-dependent kinase inhibitor p27<sup>Kip1</sup> interacts with the aryl hydrocarbon receptor and negatively regulates its transcriptional activityDaniel J Elson, Bach D Nguyen, Rhand Wood, et al.
Optics Express|October 19, 2017
Investigation of bandwidth loading in optical fibre transmission using amplified spontaneous emission noiseDaniel J Elson, Gabriel Saavedra, Kai Shi, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 18, 2019
Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell deliveryErin Morgan, John T Gamble, Martin C Pearce, et al.
Optics Letters|May 1, 2026
Fiber link stabilization with a multicore fiber amplifierYifan Liu, Takuma Nakamura, Daniel J Elson, et al.
The FEBS Journal|November 19, 2022
11-Cl-BBQ, a select modulator of AhR-regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27<sup>Kip1</sup>Bach D Nguyen, Brenna L Stevens, Daniel J Elson, et al.
Scientific Reports|February 26, 2021
Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal diseaseKevin A Lidberg, Andrew J Annalora, Marija Jozic, et al.
Scientific Reports|May 18, 2021
Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal diseaseKevin A Lidberg, Andrew J Annalora, Marija Jozic, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biology|April 28, 2023
Tumor-Suppressive Functions of the Aryl Hydrocarbon Receptor (AhR) and AhR as a Therapeutic Target in CancerDaniel J Elson, Siva K Kolluri
Optics Letters|December 24, 2015
High spectral density transmission emulation using amplified spontaneous emission noiseDaniel J Elson, Lidia Galdino, Robert Maher, et al.
Biology|April 3, 2021
The Zebrafish Xenograft Models for Investigating Cancer and Cancer TherapeuticsJohn T Gamble, Daniel J Elson, Juliet A Greenwood, et al.
FEBS Letters|June 23, 2022
The cyclin-dependent kinase inhibitor p27<sup>Kip1</sup> interacts with the aryl hydrocarbon receptor and negatively regulates its transcriptional activityDaniel J Elson, Bach D Nguyen, Rhand Wood, et al.
Optics Express|October 19, 2017
Investigation of bandwidth loading in optical fibre transmission using amplified spontaneous emission noiseDaniel J Elson, Gabriel Saavedra, Kai Shi, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 18, 2019
Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell deliveryErin Morgan, John T Gamble, Martin C Pearce, et al.
Optics Letters|May 1, 2026
Fiber link stabilization with a multicore fiber amplifierYifan Liu, Takuma Nakamura, Daniel J Elson, et al.
The FEBS Journal|November 19, 2022
11-Cl-BBQ, a select modulator of AhR-regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27<sup>Kip1</sup>Bach D Nguyen, Brenna L Stevens, Daniel J Elson, et al.
Scientific Reports|February 26, 2021
Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal diseaseKevin A Lidberg, Andrew J Annalora, Marija Jozic, et al.
Scientific Reports|May 18, 2021
Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal diseaseKevin A Lidberg, Andrew J Annalora, Marija Jozic, et al.
Pageof 2